Loading...
Loading...
Among the 5 tracked institutional investors we monitor, ACET (ADICET BIO INC) is held with a combined value of $7.13M across 978,498 shares. The largest holder is CITADEL ADVISORS LLC with a position worth $2.60M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 2 funds increased their holdings. 1 fund reduced its position.
Total Institutional Value
$7.13M
Total Shares Held
978,498
Institutional Holders
5
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | $2.60M | 0.00% | +254.2% |
| 2 | VANGUARD GROUP INC | $2.45M | 0.00% | New |
| 3 | RENAISSANCE TECHNOLOGIES LLC | $1.58M | 0.00% | -4.3% |
| 4 | BlackRock, Inc. | $249.14K | 0.00% | - |
| 5 | STATE STREET CORP | $246.67K | 0.00% | +39.9% |
As of the latest SEC 13F filings, CITADEL ADVISORS LLC is the largest institutional holder of ACET with a position worth $2.60M, representing 0.00% of their portfolio. In total, 5 institutional investors hold ACET with a combined value of $7.13M.
In the most recent quarter, 1 fund opened a new position in ACET. Additionally, 2 increased their holdings and 1 reduced their positions.
Institutional investors hold $7.13M worth of ACET stock across 5 positions. The largest institutional holder is CITADEL ADVISORS LLC with $2.60M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For ACET, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their ACET positions.